A new research paper, which has looked at a collection of previous studies over the past few years, has concluded that women who are taller than average of who have high body mass indexes, are at a greater risk from ovarian cancer.
The journal Public Library of Science Medicine contains a paper which argues that women's height and body mass index is related to their risk of developing ovarian cancer. The paper contains a review of many published and unpublished data from epidemiological studies. The paper examines the association between height, body mass index, and the risk of developing ovarian cancer.
According to the BBC, the research was undertaken University of Oxford in England. The authors examined individual data on 25,157 women with ovarian cancer and 81,311 women without ovarian cancer.
The conclusion of the review is that ovarian cancer rates are associated with height body mass index. In terms of height, for every two inches (or five cm) increase in height, the risk of developing ovarian cancer increases by seven per cent. The statement signifies that a 165 cm tall woman is fourteen per cent more prone to develop cancer of ovaries than a woman who is 155 cm tall.
According to the Daily Mail, the researchers say that "with women in the Western world gradually getting taller as well as fatter, it is important to make the link."
The NY Daily News adds that it is not only height which matters for obesity is also an issue. The media outlet quotes Valerie Beral, one of the lead researchers, as saying:
“Ovarian cancer can be added to the list [of cancers linked to obesity. Women can reduce their risk of this and many other diseases by keeping to a healthy weight.”
The findings support similar studies, according to The Scientist. The link between height and cancer risk seems to be common to many different types of cancer and in different people; suggesting that there may be a basic common factor at play.